64 related articles for article (PubMed ID: 1365743)
1. [Pharmacologic interactions between quinolones and oral hypoglycemic agents. An experimental study on rabbits].
Losasso C; Loffreda A; Angrisani M; Marabese I; Vacca C; Rossi F
G Ital Chemioter; 1992; 39(1-3):1-4. PubMed ID: 1365743
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of fluoroquinolones on dapsone induced erythrolysis.
Chatterjee N; Mehta VL; Tayal G
Indian J Exp Biol; 1995 Nov; 33(11):883-5. PubMed ID: 8786165
[TBL] [Abstract][Full Text] [Related]
3. [Modulation by quinolones of the in vitro proliferative response of splenic cells of the mouse and IL 1 production].
Guenounou M; Ronco E; Kodari E; Vacheron F; Momrikof V
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):785-9. PubMed ID: 3309816
[TBL] [Abstract][Full Text] [Related]
4. [Growing incidence of nalidixic acid resistance and sensitivity to quinolones in Salmonella typhimurium strains isolated from man or animal].
Heurtin-Le Corre C; Donnio PY; Bonnier M; Travert MF; Lacourt A; Avril JL
Pathol Biol (Paris); 1998 Oct; 46(8):587-90. PubMed ID: 9871929
[TBL] [Abstract][Full Text] [Related]
5. Induced and photoinduced DNA damage by quinolones: ciprofloxacin, ofloxacin and nalidixic acid determined by comet assay.
Sánchez G; Hidalgo ME; Vivanco JM; Escobar J
Photochem Photobiol; 2005; 81(4):819-22. PubMed ID: 15691228
[TBL] [Abstract][Full Text] [Related]
6. [The new quinolones].
Lontie M
J Pharm Belg; 1989; 44(4):292-301. PubMed ID: 2691640
[TBL] [Abstract][Full Text] [Related]
7. The importance of active efflux systems in the quinolone resistance of clinical isolates of Salmonella spp.
Escribano I; Rodríguez JC; Cebrian L; Royo G
Int J Antimicrob Agents; 2004 Nov; 24(5):428-32. PubMed ID: 15519472
[TBL] [Abstract][Full Text] [Related]
8. [Susceptibility to quinolones of Salmonella isolated from men and animals].
Avril JL; Couete I; Travert MF; Autuly F; Plessis P
Pathol Biol (Paris); 1995 Apr; 43(4):270-3. PubMed ID: 7567113
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of new quinolones as antituberculosis drugs].
Kawahara S; Tada A; Nagare H
Kekkaku; 1999 Jan; 74(1):71-5. PubMed ID: 10067058
[TBL] [Abstract][Full Text] [Related]
10. Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes.
Milberg P; Hilker E; Ramtin S; Cakir Y; Stypmann J; Engelen MA; Mönnig G; Osada N; Breithardt G; Haverkamp W; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):647-54. PubMed ID: 17388913
[TBL] [Abstract][Full Text] [Related]
11. Drug interactions of gliclazide and other sulfonylureas in protein binding in vitro and in hypoglycemic effect in rats.
Fujii T; Nakamura K; Furukawa H; Watanabe M; Kuwashima J; Miyazaki H; Kawashima K; Kuzuya T
Arzneimittelforschung; 1983; 33(11):1535-7. PubMed ID: 6686448
[TBL] [Abstract][Full Text] [Related]
12. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
Croize J; Le Noc P; Bryskier A; Robert J
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
[TBL] [Abstract][Full Text] [Related]
13. [Effect of quinolones on mice experimental infection by Plasmodium berghei and their possible therapeutic usefulness].
Amato Neto V; Braz LM; Campos R; Matsubara L; Silva Mde F; Pinto PL
Rev Hosp Clin Fac Med Sao Paulo; 1993; 48(3):116-8. PubMed ID: 8248700
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
Wise R; Griggs D; Andrews JM
Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
[TBL] [Abstract][Full Text] [Related]
15. Drug interaction: rifampicin and glibenclamide.
Surekha V; Peter JV; Jeyaseelan L; Cherian AM
Natl Med J India; 1997; 10(1):11-2. PubMed ID: 9069698
[TBL] [Abstract][Full Text] [Related]
16. The fluoroquinolones for urinary tract infections: a review.
Cunha BA
Adv Ther; 1994; 11(6):277-96. PubMed ID: 10150268
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of the in vitro activity of 6 quinolones on Pseudomonas sp].
Lesage D; Delisle-Mizon F; Vergez P; Daguet GL
Pathol Biol (Paris); 1985 May; 33(5):412-5. PubMed ID: 3162141
[TBL] [Abstract][Full Text] [Related]
18. [Effect of antiinflammatory agents on the accumulation of ofloxacin in human polymorphonuclear leukocytes].
Orero A; Cantón E; Bermejo MV; Velert MM; Cabrera E; Pemán J; Gobernado M
Rev Esp Quimioter; 1999 Jun; 12(2):144-8. PubMed ID: 10562676
[TBL] [Abstract][Full Text] [Related]
19. [In vivo bactericidal effect of ciprofloxacin, ofloxacin and pefloxacin against Staphylococcus aureus].
Tronel H; Voiriot P; Weber M; Dopff C; Dewachter P; Phelisse F; Dureux JB
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):578-81. PubMed ID: 2797882
[TBL] [Abstract][Full Text] [Related]
20. Teicoplanin with other drugs: possible pharmacological interactions.
Angrisani M; Cazzola M; Loffreda A; Matera MG; Rossi F
J Chemother; 1993 Feb; 5(1):22-6. PubMed ID: 8459261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
